Healthcare / Medical - Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

LON/0G8X stock hub

LON/0G8X has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0G8Xis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

10.5M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0G8X

In the news

Latest news · LON/0G8X

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-281.3

P25 -54.2P50 2.1P75 13.7

ROIC-131.8

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0G8X market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

156

Groups with data

Currency

SEK

Showing 156 of 156 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	UK
Employees	13
Employees Change	4%
Employees Change Percent	44.44
Enterprise value	SEK 6.1M
Exchange	London Stock Exchange
Financial currency	SEK
First seen	2026-05-10
Industry	Medical - Diagnostics & Research
Isin	SE0006091997
Last refreshed	2026-05-10
Market cap	SEK 10.5M
Price	SEK 0.2
Price currency	SEK
Rev Per Employee	5,558.08x
Sector	Healthcare
Sic	2836
Symbol	lon/0G8X
Website	https://www.immunovia.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-80.5%
EV Earnings	-0.72x
EV/Sales	84.02x
P/B ratio	2.85x
P/S ratio	145.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	69.27%
Gross Profit	SEK 50,053
Gross Profit Growth	-35.55%
Gross Profit Growth Q	102.16%
Gross Profit Growth5 Y	-56.4%
Net Income	SEK -8.5M
Net Income Growth Years	0%
Pretax Margin	-11,735.34%
Profit Per Employee	SEK -652,259
ROA	-91.31
Roa5y	-65.7
ROCE	-172
ROE	-281.3
Roe5y	-171.1
ROIC	-131.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-27.14%
Cagr3y	-61.56%
Cagr5y	-69.84%
EPS Growth Years	2
Revenue Growth	-6.97x
Revenue Growth Q	205.04x
Revenue Growth Years	0x
Revenue Growth3 Y	-15.09x
Revenue Growth5 Y	14.03x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SEK 0.02
Assets	SEK 5.2M
Cash	SEK 4.5M
Current Assets	SEK 4.7M
Current Liabilities	SEK 1.5M
Equity	SEK 3.7M
Liabilities	SEK 1.5M
Long Term Assets	SEK 570,618
Long Term Liabilities	SEK -266
Net Cash	SEK 4.5M
Net Cash By Market Cap	SEK 42.37
Net Cash Growth	49.33%
Net Debt Equity	SEK -1.21
Tangible Book Value	SEK 3.2M
Tangible Book Value Per Share	SEK 0
WACC	18.88

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.05
Net Working Capital	SEK -1.3M
Quick ratio	3.04
Working Capital	SEK 3.1M
Working Capital Turnover	SEK 0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-243.45%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-27.13%
200-day SMA	1.28
3Y total return	-94.32%
50-day SMA	0.2
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.75%
All Time High	292
All Time High Change	-99.93%
All Time High Date	2020-10-12
All Time Low	0.15
All Time Low Change	28.63%
All Time Low Date	2026-03-19
ATR	0.01
Beta	2.66
Ch YTD	-14.4
High	0.2
High52	0.93
High52 Date	2025-09-02
High52ch	-78.53%
Low	0.2
Low52	0.15
Low52 Date	2026-03-19
Low52ch	28.63%
Ma50ch	-1.73%
Price vs 200-day SMA	-84.5%
RSI	48.68
RSI Monthly	35.1
RSI Weekly	26.49
Sharpe ratio	-1.16x
Sortino ratio	-2.16
Total Return	-243.45%
Tr YTD	-14.4
Tr1m	7.12%
Tr1w	-2.29%
Tr3m	-0.7%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SEK -6.4M
Operating margin	-8,808.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	607,392,862%
Net Borrowing	-80,389.9
Shares Insiders	9.65%
Shares Institutions	13.77%
Shares Qo Q	27.11%
Shares Yo Y	243.45%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	91,872.5x
Bv Per Share	0.01
Ch1m	7.12
Ch1w	-2.31
Ch1y	-43.34
Ch3m	-0.7
Ch3y	-95.59
Ch5y	-99.82
Ch6m	-38.8
Change	0%
Change From Open	0
Depreciation Amortization	-66,182.4
Dollar Volume	7,864.2
Earnings Date	2026-05-07
EBIT	SEK -6.4M
EBITDA	SEK -6.4M
EPS	SEK -0.02
F Score	2
Financing CF	7,920,908
Fiscal Year End	December
Founded	2,007
Investing CF	453,026
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Ma150	0.66
Ma150ch	-69.92%
Ma20	0.19
Ma20ch	3.12%
Net CF	2,371,681
Next Earnings Date	2026-08-06
Open	0.2
Position In Range	0
Ppne	40,115.4
Price Date	2026-05-08
Ptbv Ratio	3.31
Relative Volume	0.43x
Revenue	72,255x
SBC By Revenue	32.16x
Share Based Comp	23,236
Tr6m	-38.8%
Volume	39,598

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0G8X pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0G8X stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0G8X?

Insider, institutional, and short-interest positioning.

Institutional ownership

+13.8%

Share of float held by funds and institutions

Insider ownership

+9.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+243.4%

Negative means the company is buying back shares.

Technical

LON/0G8X momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.7

Neutral momentum band

Price vs 200-day MA

-84.5%

50/200-day relationship not available

Beta (5Y)

2.66

More volatile than the market

Sharpe ratio

-1.16

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0G8X

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0G8X stock rating?

lon/0G8X is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0G8X analysis?

The full report lives at /stocks/lon/0G8X/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0G8X?

The latest report frames lon/0G8X around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0G8X page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.